Response of Wegener's granulomatosis to anti-CD20 chimeric monoclonal antibody therapy

Arthritis and Rheumatism

Volumn 44, Issue 12, 2001, Pages 2836-2840

  Specks, Ulrich ^a   Fervenza, Fernando C ^a   McDonald, Thomas J ^a   Hogan, Marie C E ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; GLUCOCORTICOID; METHOTREXATE; MONOCLONAL ANTIBODY; MYCOPHENOLIC ACID; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISONE; RITUXIMAB;

AGED; ARTICLE; B LYMPHOCYTE; BONE MARROW TOXICITY; CASE REPORT; DISEASE ACTIVITY; DRUG MEGADOSE; HUMAN; LYMPHOCYTE COUNT; MALE; PRIORITY JOURNAL; RELAPSE; REMISSION; TREATMENT FAILURE; VASCULITIS; WEGENER GRANULOMATOSIS;

AGED; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODIES, MONOCLONAL; ANTIGENS, CD20; ANTINEOPLASTIC AGENTS; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LYMPHOCYTE COUNT; MALE; REMISSION INDUCTION; WEGENER GRANULOMATOSIS;

EID: 0035674612     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200112)44:12<2836::AID-ART471>3.0.CO;2-W     Document Type: Article

References (15)

1. An interdisciplinary approach to the care of patients with Wegener's granulomatosis: Long-term outcome in 155 patients
2. Antineutrophil cytoplasmic antibodies
3. Is Wegener's granulomatosis an autoimmune disease?
4. Monoclonal antibody therapy in lymphoid malignancies
5. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: Half of patients respond to a four-dose treatment program
6. A disease-specific activity index for Wegener's granulomatosis: Modification of the Birmingham vasculitis activity score
7. Suppression of human B lymphocyte function by cyclophosphamide
8. Characterization of a human B lymphocyte-specific antigen
9. Rituximab for myasthenia gravis developing after bone marrow transplant
10. Anti-CD20 chimeric monoclonal antibody treatment of refractory immune-mediated thrombocytopenia in a patient with chronic graft-versus-host disease
11. Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: A prospective study
12. Spontaneous and induced immunoglobulin synthesis and anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis: Relation to leukocyte subpopulations in blood and active lesions
13. Differential B- and T-cell activation in Wegener's granulomatosis
14. Humoral immunity due to long-lived plasma cells
15. T and B cell responses to neutrophil cytoplasmic antigens in systemic vasculitis